Related Experiment Video
Updated: Aug 26, 2025

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Acute Myopericarditis After the Third Vaccination of BNT162b2 in a Middle-Aged Man
Satoshi Nakawatase1, Takaharu Hayashi1, Satoki Nakamura2
1Cardiovascular Medicine, Osaka Police Hospital, Osaka, JPN.
Abstract:
Messenger ribonucleic acid (mRNA) vaccines against coronavirus disease 2019 (COVID-19) are highly effective in preventing and decreasing disease severity, but the duration of the effect is attenuated over time and repeated vaccination is required. A 41-year-old Japanese male presented to our hospital with chest pain three days after receiving the third dose of the BNT162b2 mRNA vaccine. After various examinations, such as endomyocardial biopsy and viral polymerase chain reaction (PCR) testing of endomyocardial biopsy tissue, we made the diagnosis of acute myopericarditis associated with booster vaccination. Here, we report a rare case of myopericarditis after booster mRNA vaccination.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
Myocarditis I: Introduction
Endocarditis III: Medical Management
Pericarditis I: Introduction

